Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Insider Transactions

Date Name Title Type Shares Traded Price Range
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,600 $3.58
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 2,200 $3.59
Aug 01, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 1,200 $3.60
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Initial Statement of Beneficial Ownership of Securities -- --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Jul 20, 2007
Vice President Finance
Vice President Finance Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 --
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 150,000 $6.90
Jul 20, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 50,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 $6.90
Jul 20, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Grant, award or other acquisition pursuant to Rule 16b-3(d) 100,000 --
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 15,000 $6.90
Jul 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 5,000 --
Jun 08, 2007
Chief Scientific Officer
Chief Scientific Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 25,000 --
Apr 11, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 70,000 $1.06
Apr 11, 2007
Director, Chairman, CEO & President
Director, Chairman, CEO & President Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 70,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --
Feb 20, 2007
Director
Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Copyright Nasdaq. Minimum 15 minutes delayed.